LEXARIA BIOSCIENCE CORP (LEXX) Stock Income Statement
NASDAQ:LEXX - Nasdaq - US52886N4060 - Common Stock - Currency: USD
| TTM (2025-2-28) | 2024 (2024-8-31) | 2023 (2023-8-31) | 2022 (2022-8-31) | 2021 (2021-8-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 525.90K | 464.30K | 230.00K | 260.00K | 720.00K | |||
| Minority Interest Expense | 11.10K | 13.30K | 50.00K | 110.00K | 160.00K | |||
| Cost Of Goods | 2.70K | 4.80K | 30.00K | 70.00K | 180.00K | |||
| Gross Profit | 523.20K | 459.50K | 190.00K | 180.00K | 550.00K | |||
| Operating Expenses | 9.91M | 6.21M | 6.73M | 7.57M | 6.06M | |||
| Research and Development | 5.18M | 2.36M | 3.67M | 1.84M | 1.26M | |||
| Selling, General, and Administrative Expenses | 4.73M | 3.85M | 3.06M | 5.72M | 4.81M | |||
| Operating Income | -9.39M | -5.75M | -6.53M | -7.38M | -5.52M | |||
| Interest Income/Expense | 7.30K | -41.40K | -180.00K | N/A | -170.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -9.39M | -5.81M | -6.71M | -7.38M | -5.69M | |||
| Net Income | -9.38M | -5.80M | -6.66M | -7.27M | -4.03M | |||
| EBITDA | -9.32M | -5.68M | -6.38M | -7.28M | -5.41M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.58 | -0.47 | -1.01 | -1.24 | -0.91 | |||
| Non GAAP EPS | -0.58 | -0.46 | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 99.49% | 98.97% | 82.61% | 69.23% | 76.39% | |||
| Profit Margin | -1784.26% | -1248.20% | -2895.65% | -2796.15% | -559.72% | |||
| Operating Profit Margin | -1785.07% | -1239.09% | -2839.13% | -2838.46% | -766.67% | |||
All data in USD